1, 3, 4-oxadiazol-2-ones as peroxisome-proliferator activated receptor delta modulators and their use in the treatment of neurological and metabolic disease | Patent Number 07638539

US 07638539 B2
Application Number11535764
Publication NumberUS 20070099964 A1
Pendency3 years, 3 months, 4 days
Filled DateSep 27, 2006
Priority DateApr 1, 2004
Publication DateMay 3, 2007
Expiration DateDec 29, 2013
Inventor/ApplicantsJochen Goerlitzer
Stefanie Keil
Wolfgang Wendler
Jean Merrill
Karen Chandross
Daniel G. McGarry
Karen Chandros
ExaminesCHU, YONG LIANG
Art Unit1626
Technology Center1600
Assignments
Aventis Holdings Inc. Sanofi
Current
Sanofiaventis Deutschland GmbhAventis Holdings Inc. SanofiSanofi
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.